Results 271 to 280 of about 157,451 (315)

Chemoprevention in postmenopausal women

Menopause, 2008
Several large, prospective trials have evaluated tamoxifen compared with placebo for breast cancer risk reduction in women at increased risk of breast cancer. Combined results from these trials demonstrate that tamoxifen at 20 mg/d reduced the incidence of breast cancer by 38%.
openaire   +2 more sources

The benefits of exercise in postmenopausal women

Australian Journal of Public Health, 1993
Abstract: Physical exercise is commonly promoted as a panacea. However many of the claimed benefits, in particular any positive effects on bone density, have not been scientifically proved. We assessed the effects of a twice‐weekly aerobic weight‐bearing exercise program on bone density in postmenopausal women.
G A, Caplan, J A, Ward, S R, Lord
openaire   +2 more sources

Postmenopausal Sexuality in Thai Women*

Asia-Oceania Journal of Obstetrics and Gynaecology, 1991
AbstractWe evaluate sexuality in 100 natural menopausal women as pertains to hormones, symptoms related to intercourse, and marital relationship with sexual desire, orgasm and coital frequency. The mean age was 56.8 years while menopausal age was 50.3 years.
S, Tungphaisal, V, Chandeying, S, Sutthijumroon, O, Krisanapan, P, Udomratn   +4 more
openaire   +2 more sources

Tamoxifen in Postmenopausal Women

Drugs & Aging, 1996
Tamoxifen is a synthetic antiestrogen with both agonist and antagonist properties. It is believed to act primarily through binding to estrogen receptors in breast cancer cells, acting as a competitive inhibitor of estrogen. Tamoxifen has a wide range of systemic effects, possibly acting on every estrogen target tissue in the body.
E, Robinson, G G, Kimmick, H B, Muss
openaire   +2 more sources

Management of Hypercholesterolaemia in Postmenopausal Women

Drugs & Aging, 2002
Increased rates of coronary heart disease (CHD) occur with advancing age in both sexes, although CHD rates in women lag behind those of men by about 10 years. There is a sharp increase in CHD rate among women after approximately 50 years of age. The reasons for this are not completely understood and are undoubtedly multifactorial.
Michael H, Davidson, Kevin C, Maki, Sherry Katz, Karp, Kate A, Ingram   +3 more
openaire   +2 more sources

Sexuality in healthy postmenopausal women

Climacteric, 2003
To assess the influence of psychosocial factors, behavior and hormones on postmenopausal sexuality.Nine hundred and ninety-nine women (age range 41-60 years) underwent physical and supplementary tests and answered questionnaires regarding sexual behavior.
S R L, Penteado, A M, Fonseca, V R, Bagnoli, J S, Assis, J A, Pinotti   +4 more
openaire   +2 more sources

Fracture prevention in postmenopausal women.

Clinical evidence, 2007
The lifetime risk of fracture in white women is 20% for the spine, 15% for the wrist, and 18% for the hip, with an exponential increase in risk beyond the age of 50 years.We conducted a systematic review and aimed to answer the following clinical question: What are the effects of treatments to prevent fractures in postmenopausal women?
Vestergaard, Peter, Mosekilde, Leif, Langdahl, Bente Lomholt   +2 more
openaire   +14 more sources

Dehydroepiandrosterone sulfate and postmenopausal women

Current Opinion in Endocrinology, Diabetes & Obesity, 2011
Levels of dehydroepiandrosterone (DHEA) are known to decline with age. In an era of increasing use of supplements to better life, the benefits of DHEA in the aging female population are controversial. The goal of this article is to critically review published studies to determine if there is a role for DHEA supplementation in postmenopausal women.Daily
Rachna M, Goel, Anne R, Cappola
openaire   +2 more sources

Androgens in postmenopausal women: a review

Menopause, 2017
Abstract There is significant interest in the use of androgen therapy for postmenopausal women. This review provides background on endogenous androgens in women, describes factors that affect circulating androgen concentrations, and examines the relationship between low levels of androgens and sexual problems.
Jan L, Shifren, Susan R, Davis
openaire   +2 more sources

Cardiovascular disease in postmenopausal women

Maturitas, 1998
With many risk factors for cardiovascular disease, myocardial infarction in particular now being well defined, it becomes increasingly clear that a majority of these factors are not only age, but also gender specific. Confidential risk factors such as smoking, hypertension, diabetes mellitus, overweight and hyperlipaemia, might have a different impact ...
openaire   +2 more sources